New search | Conferencedetail
Print view
 
 

Antibodies and Antibody Drug Conjugates

evvnt Platform / evvnt
Conference themes
Antibodies and antibody drug conjugates (ADCs) have the potential to make a ground-breaking impact upon medicinal therapies, diagnostics and characterization of diseases. There is massive potential for ADCs to be used in the development of targeted solid tumour therapies, due to their ability to act as precisely and effectively on target antigens.

Join us this April 2018, as SMi's ADC Summit conference brings together industry experts from leading life science and pharmaceutical companies.
Professional congress organizer (PCO)
SMi Group
 

Enquiries and Registration:

Ms. Pav Solanki
 
Categories
Internal Medicine
Languages
English
Congress fees
GBP 1.499,00
(Standard Price (early-bird rates available): GBP 1499)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

European Public Health Association (EUPHA)Helix - Forschung & Beratung WienÄrztekammer für WienÄrzte der WeltAnästhesie in Entwicklungsländern e. V.Hilfswerk AustriaSwiss Tropical and Public Health InstituteÖsterreichisches Rotes Kreuz

Facebook

Give us your professional opinion

Start survey

Start survey